David Nierengarten: Stocks like Y-mAbs Therapeutics Which Have Advanced Assets as Well as Upside Potential
For more on David Nierengarten’s: Wedbush: Y-mAbs Could Attract Investor Attention As Market Volatility Grows
David Nierengarten: Y-mAbs Therapeutics Should be Particularly Attractive for Investors.
For more on David Nierengarten’s comments: Wedbush: Y-mAbs Could Attract Investor Attention As Market Volatility Grows
Robert Driscoll: Cidara’s Partnership with Mundipharma is a Significant Positive
For more on Robert Driscoll’s comments: Wedbush Recommends Buying Cidara Shares After Rezafungin Deal
Robert Driscoll: We See Substantial Synergies Between Both Cidara and Mundipharma Given Mundipharma Already has a Significant Global Commercial Reach with Annual Sales Over €2B
For more on Robert Driscoll’s comments: Wedbush Recommends Buying Cidara Shares After Rezafungin Deal
Technology Sector Investors in a Defensive Mode
Michael Pachter: Few Near-Term Catalysts Ahead of the Nov. 15 Launch of EA’s Star Wars Jedi: Fallen Order
For more on Michael Pachter’s comments: Activision Upgraded As Video Game Publisher Improves Key Franchises
Upcoming iPhone Models Could Boost Apple Stock Regardless of Trade Tariffs
Michael Pachter: They are Hopeful That A Lot of People in the Chain of Decision-Making is Thinking About Life After the DOD and Life In the Private Sector.
For more on Michael Pachter’s comments: Amazon hiring for cloud services, Alexa products at HQ2 in Arlington, Va.
Daniel Ives: There Has Been an Accelerations of Large Enterprise Cloud Deals During the Second Quarter in the U.S. and Europe and That Microsoft is Poised to Win Many of Them
For more on Daniel Ives’ comments: Here’s A Reason To Own Microsoft’s Stock: Its Red-Hot Cloud Computing Business
Michael Pachter: Few Near-term Catalysts Ahead of Nov. 15 Launch of “Star Wars Jedi: Fallen Order
For more on Michael Pachter’s comments: Activision Upgraded As Video Game Publisher Improves Key Franchises